Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 11/01/2001
Publisher: CLSI
File Format: PDF
$122.00$245.21
Published:01/11/2001
Pages:16
This document provides general guidelines for performing the fibrinogen assay in the clinical laboratory. It also includes reporting of results and in vivo and in vitro conditions that may alter results. (See related publication H21-A3 in this section.)
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Determination of Coagulation Factor Activities Using the One-Stage Clotting Assay, 2nd Edition, H48Ed2E
$90.00 $180.00
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; 4th Edition M23Ed4E
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Twelfth Edition/Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Fifth Informational Supplement
$142.00 $284.82
Performance Standards for Antimicrobial Susceptibility Testing - Twenty-Sixth Informational Supplement, M100S24E
$102.00 $205.40
